-
-
-
-
-
-
-
Pliant Therapeutics, Inc. (PLRX) Tops Q3 EPS by 13c
-
-
-
-
-
-
-
Pliant Therapeutics (PLRX) PT Lowered to $1.50 at Citi
-
-
-
-
-
-
-
Aligos Therapeutics Strengthens Senior Leadership Team with the Appointment of Hardean Achneck, MD as Chief Medical Officer
-
-
-
-
-
-
-
Pliant Therapeutics Provides Corporate Update and Reports Fourth Quarter 2023 Financial Results
-
-
-
-
-
-
-
Pliant Therapeutics Provides Corporate Update and Reports Fourth Quarter 2022 Financial Results
-
-
-
-
-
-
-
Pliant Therapeutics Provides Corporate Update and Reports First Quarter 2022 Financial Results
-
-
-
-
-
-
-
Pliant Therapeutics Provides Corporate Update and Reports Third Quarter 2021 Financial Results
-
1,222,633 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

